Friday, 12 March 2010
  • Contact Us
  • Search
logo.png
  • Home
  • About us
    • Corporate Overview
    • History
    • Management Team
    • Advisory Boards
    • Partnering & Licensing
    • Contact
      • Contact Us
      • How to find us
      • Impressum
  • News
    • Current News
    • Current Publications
    • News Archive
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
      • 2003
      • 2002
      • 2001
      • 2000
      • 1999
      • 1998
    • Publications Archive
      • RESprotect Publications
      • Other relevant Publications
    • Newsletter
  • Chemogenomics
  • Product Portfolio
    • Pipeline Summary
    • RP101
      • RP101 Inhibition
      • Hsp27
        • Key Effects
        • Interaction
      • Hsp27 Suppression
      • Pancreatic Cancer
        • The Role of Hsp27
        • Clinical Effects of RP101
      • Summary of Clinical Trials
      • Safety
      • Competitive Advantage
    • 2nd Generation

Navigation

  • Current News
  • Current Publications
  • News Archive
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
    • 2003
    • 2002
    • 2001
    • 2000
    • 1999
    • 1998
  • Publications Archive
    • RESprotect Publications
    • Other relevant Publications
  • Newsletter
Home arrow News arrow STEP Award 2008
STEP Award 2008 PDF Print E-mail
The RESprotect GmbH has been nominated as a finalist of the STEP Award 2008.
 
STEP Award 2008

 
[ Back ]

Copyright © 2009 , RESprotect GmbH - Prevention of Chemoresistance - Fiedlerstr. 34, 01307 Dresden,
Tel: +49 351 / 450 32 00 Fax: +49 351 / 450 32 10
, http://www.resprotect.de
, produced by //infoworks